{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:47Z","timestamp":1792787927438,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Talent Training Fund Project of the First People\u2019s Hospital of Lianyungang","award":["F202309"],"award-info":[{"award-number":["F202309"]}],"id":[{"id":"https:\/\/ror.org\/03617rq47","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16572-4","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:25:09Z","timestamp":1784381109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcription factor activity profiling uncovers prognostic subtypes and a novel oncogenic role for PRDM4 in NSMP endometrial carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Sisi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1095-4437","authenticated-orcid":false,"given":"Wen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"4","key":"16572_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/path.5608","volume":"253","author":"J Huvila","year":"2021","unstructured":"Huvila J, Pors J, Thompson EF, Gilks CB. Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis. J Pathol. 2021;253(4):355\u201365.","journal-title":"J Pathol"},{"issue":"8","key":"16572_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/PAS.0000000000002402","volume":"49","author":"F Zhou","year":"2025","unstructured":"Zhou F, Qin L, Huang S, et al. Pilomatrix-like High-grade Endometrial Carcinoma: An Underdiagnosed Entity With Aggressive Clinicopathologic Features. Am J Surg Pathol. 2025;49(8):818\u201329. Published 2025 Apr 9.","journal-title":"Am J Surg Pathol"},{"key":"16572_CR3","doi-asserted-by":"publisher","first-page":"1586315","DOI":"10.3389\/fimmu.2025.1586315","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Liu N, Guo X, et al. The immune microenvironment in endometrial carcinoma: mechanisms and therapeutic targeting. Front Immunol. 2025;16:1586315. Published 2025 Jul 17.","journal-title":"Front Immunol"},{"issue":"1","key":"16572_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12944-023-01868-2","volume":"22","author":"W Li","year":"2023","unstructured":"Li W, Xu Y, Zeng X, et al. Etiological relationship between lipid metabolism and endometrial carcinoma. Lipids Health Dis. 2023;22(1):116. https:\/\/doi.org\/10.1186\/s12944-023-01868-2. Published 2023 Aug 4.","journal-title":"Lipids Health Dis"},{"key":"16572_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ygyno.2025.05.001","volume":"197","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Pang J, Zhou Y, et al. FR\u03b1 expression in advanced endometrial carcinoma: Clinicopathological, molecular, and prognosis correlates. Gynecol Oncol. 2025;197:146\u201354.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"16572_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12885-022-09180-5","volume":"22","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Xia T, Qi C, Du J, Ye C. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. BMC Cancer. 2022;22(1):77. Published 2022 Jan 18.","journal-title":"BMC Cancer"},{"key":"16572_CR7","doi-asserted-by":"publisher","unstructured":"Cabrera S, de la Calle I, Baulies S, et al. Screening strategies to improve early diagnosis in endometrial cancer. J Clin Med. 2024;13(18):5445. https:\/\/doi.org\/10.3390\/jcm13185445.","DOI":"10.3390\/jcm13185445"},{"issue":"2","key":"16572_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.48095\/cccg2024128","volume":"89","author":"Z Ballov\u00e1","year":"2024","unstructured":"Ballov\u00e1 Z, Ga\u0161parov\u00e1 P, Sit\u00e1\u0161 M, Dosedla E. A new perspective on Endometrial Carcinoma classification and management strategies in context of molecular subtypes. Poh\u013ead na klasifi k\u00e1ciu a mana\u017ement endometri\u00e1lneho karcin\u00f3mu v kontexte molekul\u00e1rnych subtypov. Ceska Gynekol. 2024;89(2):128\u201332.","journal-title":"Ceska Gynekol"},{"issue":"7","key":"16572_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/his.15411","volume":"86","author":"CY Shin","year":"2025","unstructured":"Shin CY, Gokbayrak B, Tao VL, et al. Prognostic values of molecular subtypes and SWI\/SNF protein expression in de-differentiated\/undifferentiated endometrial carcinoma. Histopathology. 2025;86(7):1053\u201363.","journal-title":"Histopathology"},{"key":"16572_CR10","doi-asserted-by":"publisher","unstructured":"Huang X, Xu L, Wang J, et al. Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism. Cell Death Discov. 2026;12(1):189. https:\/\/doi.org\/10.1038\/s41420-026-03071-5.","DOI":"10.1038\/s41420-026-03071-5"},{"issue":"1","key":"16572_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41420-025-02325-y","volume":"11","author":"L Ma","year":"2025","unstructured":"Ma L, Huang W, Liang X, et al. Inhibition of lanosterol synthase linking with MAPK\/JNK signaling pathway suppresses endometrial cancer [J]. Cell death discovery. 2025;11(1):55.","journal-title":"Cell death discovery"},{"issue":"3","key":"16572_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.5375","volume":"250","author":"N Singh","year":"2020","unstructured":"Singh N, Piskorz AM, Bosse T, et al. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol. 2020;250(3):336\u201345.","journal-title":"J Pathol"},{"issue":"5","key":"16572_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","volume":"29","author":"S Kommoss","year":"2018","unstructured":"Kommoss S, McConechy MK, Kommoss F, et al. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann Oncol. 2018;29(5):1180\u20138.","journal-title":"Ann Oncol"},{"issue":"19","key":"16572_CR14","doi-asserted-by":"publisher","first-page":"11684","DOI":"10.3390\/ijms231911684","volume":"23","author":"D Arciuolo","year":"2022","unstructured":"Arciuolo D, Travaglino A, Raffone A, et al. TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives. Int J Mol Sci. 2022;23(19):11684. Published 2022 Oct 2.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"16572_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41420-024-02204-y","volume":"10","author":"H Ueda","year":"2024","unstructured":"Ueda H, Ishiguro T, Mori Y, et al. Glycolysis-mTORC1 crosstalk drives proliferation of patient-derived endometrial cancer spheroid cells with ALDH activity [J]. Cell death discovery. 2024;10(1):435.","journal-title":"Cell death discovery"},{"issue":"1","key":"16572_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-024-01898-4","volume":"10","author":"S Wei","year":"2024","unstructured":"Wei S, Zhang J, Zhao R, et al. Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K\/AKT\/HIF-1\u03b1 signal pathway in endometrial carcinoma [J]. Cell death discovery. 2024;10(1):121.","journal-title":"Cell death discovery"},{"issue":"3","key":"16572_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.21037\/jgo.2018.01.09","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang C, Gong J, Tu TY, Lee PP, Fakih M. Immune profiling of microsatellite instability-high and polymerase \u03b5 (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy. J Gastrointest Oncol. 2018;9(3):404\u201315.","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"16572_CR18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/jcm14041385","volume":"14","author":"MB Anca-Stanciu","year":"2025","unstructured":"Anca-Stanciu MB, Manu A, Olinca MV, et al. Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes. J Clin Med. 2025;14(4):1385. Published 2025 Feb 19.","journal-title":"J Clin Med"},{"issue":"5","key":"16572_CR19","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.modpat.2023.100123","volume":"36","author":"L Irshaid","year":"2023","unstructured":"Irshaid L, Costigan DC, Dong F, Matulonis UA, Nucci MR, Kolin DL. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups. Mod Pathol. 2023;36(5):100123.","journal-title":"Mod Pathol"},{"key":"16572_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2022.12.019","volume":"171","author":"A Jamieson","year":"2023","unstructured":"Jamieson A, Singh N, Huvila J, Gilks CB, McAlpine JN. The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype. Gynecol Oncol. 2023;171:159\u201361.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"16572_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/his.15531","volume":"88","author":"M Grillini","year":"2026","unstructured":"Grillini M, Lenzi J, Ceccarelli C, et al. Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype. Histopathology. 2026;88(2):442\u201356.","journal-title":"Histopathology"},{"issue":"6","key":"16572_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/ijgc-2023-005111","volume":"34","author":"A Onoprienko","year":"2024","unstructured":"Onoprienko A, Hofstetter G, Muellauer L, et al. Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. Int J Gynecol Cancer. 2024;34(6):840\u20136. Published 2024 Jun 3.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"16572_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/AOG.0000000000006080","volume":"146","author":"AA Secord","year":"2025","unstructured":"Secord AA, Powell MA, McAlpine J. Molecular Characterization and Clinical Implications of Endometrial Cancer. Obstet Gynecol. 2025;146(5):660\u201371.","journal-title":"Obstet Gynecol"},{"key":"16572_CR24","doi-asserted-by":"publisher","first-page":"154563","DOI":"10.1016\/j.prp.2023.154563","volume":"247","author":"I Kitazono","year":"2023","unstructured":"Kitazono I, Akahane T, Yokoyama S, et al. Surface epithelial slackening pattern in endometrioid carcinoma: A morphological feature for differentiating the POLE mutation-subtype from the no specific molecular profile subtype. Pathol Res Pract. 2023;247:154563.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"16572_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/PGP.0000000000001113","volume":"45","author":"A Leino","year":"2026","unstructured":"Leino A, Nostolahti A, Ahtikoski A, Huvila J. Molecular Subtype and Mutational Profile of Endometrial Atypical Hyperplasia\/Endometrioid Intraepithelial Neoplasia. Int J Gynecol Pathol. 2026;45(2):120\u20138.","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"16572_CR26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.gastro.2021.04.042","volume":"161","author":"K Rajam\u00e4ki","year":"2021","unstructured":"Rajam\u00e4ki K, Taira A, Katainen R, et al. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer. Gastroenterology. 2021;161(2):592\u2013607.","journal-title":"Gastroenterology"},{"issue":"1","key":"16572_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.7150\/thno.47525","volume":"11","author":"X Bao","year":"2021","unstructured":"Bao X, Wang G, Yu S, et al. Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics. Theranostics. 2021;11(1):132\u201346. Published 2021 Jan 1.","journal-title":"Theranostics"},{"issue":"2","key":"16572_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 2018;173(2):291\u2013e3046.","journal-title":"Cell"},{"key":"16572_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2023.10.001","volume":"97","author":"M Saitoh","year":"2023","unstructured":"Saitoh M. Transcriptional regulation of EMT transcription factors in cancer. Semin Cancer Biol. 2023;97:21\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"13","key":"16572_CR30","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.molcel.2022.04.019","volume":"82","author":"J Vibert","year":"2022","unstructured":"Vibert J, Saulnier O, Collin C, et al. Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions. Mol Cell. 2022;82(13):2458\u2013e24719.","journal-title":"Mol Cell"},{"key":"16572_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.03.002","volume":"100","author":"AQ Khan","year":"2024","unstructured":"Khan AQ, Hasan A, Mir SS, Rashid K, Uddin S, Steinhoff M. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy. Semin Cancer Biol. 2024;100:1\u201316.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"16572_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.molcel.2021.12.008","volume":"82","author":"N Alerasool","year":"2022","unstructured":"Alerasool N, Leng H, Lin ZY, Gingras AC, Taipale M. Identification and functional characterization of transcriptional activators in human cells. Mol Cell. 2022;82(3):677\u2013e6957.","journal-title":"Mol Cell"},{"issue":"4","key":"16572_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2024.02.011","volume":"42","author":"Q Deng","year":"2024","unstructured":"Deng Q, Lakra P, Gou P, et al. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024;42(4):605\u2013e62211.","journal-title":"Cancer Cell"},{"issue":"23","key":"16572_CR34","doi-asserted-by":"publisher","first-page":"e40696","DOI":"10.1016\/j.heliyon.2024.e40696","volume":"10","author":"XG Pappalardo","year":"2024","unstructured":"Pappalardo XG, Jansen G, Amaradio M, et al. Inferring gene regulatory networks of ALS from blood transcriptome profiles. Heliyon. 2024;10(23):e40696. Published 2024 Nov 26.","journal-title":"Heliyon"},{"key":"16572_CR35","doi-asserted-by":"publisher","first-page":"780804","DOI":"10.3389\/fimmu.2021.780804","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li M, Wang Z, et al. Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18\/IL18R1\/HIF-1 Signaling Pathway Axis. Front Immunol. 2022;12:780804. Published 2022 Jan 5.","journal-title":"Front Immunol"},{"issue":"1","key":"16572_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12920-020-00800-2","volume":"13","author":"B Yu","year":"2020","unstructured":"Yu B, Chen L, Zhang W, et al. TOP2A and CENPF are synergistic master regulators activated in cervical cancer. BMC Med Genomics. 2020;13(1):145. Published 2020 Oct 6.","journal-title":"BMC Med Genomics"},{"issue":"8","key":"16572_CR37","first-page":"1059","volume":"12","author":"F Zhao","year":"2023","unstructured":"Zhao F, Guo X, Li X, et al. Identification and Expressional Analysis of Putative PRDI-BF1 and RIZ Homology Domain-Containing Transcription Factors in Mulinia lateralis. Biology (Basel). 2023;12(8):1059. Published 2023 Jul 27.","journal-title":"Biology (Basel)"},{"issue":"1","key":"16572_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, et al. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics [J]. Cell death discovery. 2025;11(1):244.","journal-title":"Cell death discovery"},{"issue":"1","key":"16572_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, et al. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma [J]. Cell death discovery. 2024;10(1):198.","journal-title":"Cell death discovery"},{"issue":"1","key":"16572_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, et al. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer [J]. Cell death discovery. 2025;11(1):262.","journal-title":"Cell death discovery"},{"issue":"1","key":"16572_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, et al. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies [J]. J translational Med. 2025;23(1):548.","journal-title":"J translational Med"},{"issue":"1","key":"16572_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, et al. Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis [J]. J translational Med. 2025;23(1):340.","journal-title":"J translational Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16572-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16572-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16572-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:11:56Z","timestamp":1791864716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16572-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16572"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16572-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Committee of the First People\u2019s Hospital of Lianyungang (Approval No.:KY-20260306004-01). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was waived for retrospective analysis of anonymous clinical data. Patient privacy and confidential information were strictly protected throughout the study. No potential conflict of interest exists in this research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1225"}}